Please use this identifier to cite or link to this item:
http://hdl.handle.net/1942/28853
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | VAN WIJMEERSCH, Bart | - |
dc.contributor.author | Boyko, Alexey N. | - |
dc.contributor.author | Broadley, Simon | - |
dc.contributor.author | Brassat, David | - |
dc.contributor.author | Dive, Dominique | - |
dc.contributor.author | Hupperts, Raymond M. M. | - |
dc.contributor.author | Lycke, Jan | - |
dc.contributor.author | Montalban, Xavier | - |
dc.contributor.author | Sharrack, Basil | - |
dc.contributor.author | Wray, Sibyl | - |
dc.contributor.author | Margolin, David H. | - |
dc.contributor.author | Chung, Luke | - |
dc.contributor.author | Daizadeh, Nadia | - |
dc.contributor.author | Chirieac, Madalina | - |
dc.contributor.author | Wiendl, Heinz | - |
dc.date.accessioned | 2019-07-31T16:26:02Z | - |
dc.date.available | 2019-07-31T16:26:02Z | - |
dc.date.issued | 2018 | - |
dc.identifier.citation | NEUROLOGY, 90 (Art N° S15) | - |
dc.identifier.issn | 0028-3878 | - |
dc.identifier.uri | http://hdl.handle.net/1942/28853 | - |
dc.description.sponsorship | Sanofi and Bayer HealthCare Pharmaceuticals. | - |
dc.language.iso | en | - |
dc.publisher | LIPPINCOTT WILLIAMS & WILKINS | - |
dc.title | Alemtuzumab Provides Durable Efficacy and Safety Over 5 Years After Switching From SC IFNB-1a: Follow-up of Patients From CARE-MS II (TOPAZ Study) | - |
dc.type | Journal Contribution | - |
local.bibliographicCitation.conferencedate | APR 21-27, 2018 | - |
local.bibliographicCitation.conferencename | 70th Annual Meeting of the American-Academy-of-Neurology (AAN) | - |
local.bibliographicCitation.conferenceplace | Los Angeles, CA | - |
dc.identifier.volume | 90 | - |
local.format.pages | 3 | - |
local.bibliographicCitation.jcat | M | - |
dc.description.notes | [Van Wijmeersch, Bart] Hasselt Univ, Rehabil, Hasselt, Belgium. [Van Wijmeersch, Bart] Hasselt Univ, MS Ctr Overpelt, BIOMED, Hasselt, Belgium. [Boyko, Alexey N.] Pirogov Russian Natl Res Univ, Moscow, Russia. [Boyko, Alexey N.] Usupov Hosp, Demyelinating Dis Ctr, Moscow, Russia. [Broadley, Simon] Griffith Univ, Sch Med, Gold Coast Campus, Southport, Qld, Australia. [Brassat, David] Univ Toulouse, Purpan Hosp, Toulouse, France. [Brassat, David] Univ Toulouse, Mixed Unit Res 1043, Toulouse, France. [Dive, Dominique] Univ Hosp Ctr Liege, Liege, Belgium. [Hupperts, Raymond M. M.] Maastricht Univ, Med Ctr, Orbis Med Centrum, Sittard, Netherlands. [Lycke, Jan] Univ Gothenburg, Gothenburg, Sweden. [Montalban, Xavier] Univ Toronto, St Michaels Hosp, Toronto, ON, Canada. [Montalban, Xavier] Hosp Univ Vall dHebron, Ctr Esclerosi Multiple Catalunya Cemcat, Toronto, ON, Canada. [Sharrack, Basil] Sheffield Teaching Hosp NHS Fdn Trust, Sheffield, S Yorkshire, England. [Wray, Sibyl] Hope Neurol, Knoxville, TN USA. [Margolin, David H.; Chung, Luke; Daizadeh, Nadia; Chirieac, Madalina] Sanofi, Cambridge, MA USA. [Wiendl, Heinz] Univ Munster, Munster, Germany. | - |
local.publisher.place | PHILADELPHIA | - |
local.type.refereed | Refereed | - |
local.type.specified | Meeting Abstract | - |
local.bibliographicCitation.artnr | S15 | - |
dc.identifier.isi | 000453090805104 | - |
item.contributor | VAN WIJMEERSCH, Bart | - |
item.contributor | Boyko, Alexey N. | - |
item.contributor | Broadley, Simon | - |
item.contributor | Brassat, David | - |
item.contributor | Dive, Dominique | - |
item.contributor | Hupperts, Raymond M. M. | - |
item.contributor | Lycke, Jan | - |
item.contributor | Montalban, Xavier | - |
item.contributor | Sharrack, Basil | - |
item.contributor | Wray, Sibyl | - |
item.contributor | Margolin, David H. | - |
item.contributor | Chung, Luke | - |
item.contributor | Daizadeh, Nadia | - |
item.contributor | Chirieac, Madalina | - |
item.contributor | Wiendl, Heinz | - |
item.accessRights | Closed Access | - |
item.fullcitation | VAN WIJMEERSCH, Bart; Boyko, Alexey N.; Broadley, Simon; Brassat, David; Dive, Dominique; Hupperts, Raymond M. M.; Lycke, Jan; Montalban, Xavier; Sharrack, Basil; Wray, Sibyl; Margolin, David H.; Chung, Luke; Daizadeh, Nadia; Chirieac, Madalina & Wiendl, Heinz (2018) Alemtuzumab Provides Durable Efficacy and Safety Over 5 Years After Switching From SC IFNB-1a: Follow-up of Patients From CARE-MS II (TOPAZ Study). In: NEUROLOGY, 90 (Art N° S15). | - |
item.fulltext | No Fulltext | - |
crisitem.journal.issn | 0028-3878 | - |
crisitem.journal.eissn | 1526-632X | - |
Appears in Collections: | Research publications |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.